Trial Profile
To Compare the Efficacy and Safety of TW vs Valsartan in the DN.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Tripterygium wilfordii Hook F (Primary) ; Valsartan
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 26 May 2010 Actual patient number (67) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.